Darktrace, the leader in Enterprise Immune System technology, has today announced that 451 Research has published a glowing report about Darktrace, in which it calls the company “the clear leader in anomaly detection driven by unsupervised machine learning”.

Darktrace is building impressive market presence with a high degree of focus on differentiated unsupervised machine learning,” says the report. “The ‘secret sauce’ for Darktrace remains depth and experience with unsupervised machine learning applied to its modeling of IT systems as organisms protected by immune systems.”

Other highlights from the report include:

   
• “Four-year-old Darktrace is the clear leader in network behavioral and anomaly detection driven by unsupervised machine learning, which requires no external context or advanced knowledge of the system.”
   
• “Key differentiation with respect to detection is seen in Darktrace’s ability to accurately judge gray-area anomalous activities.”
   
• “The company’s sharp eye for opportunities in IoT, and a potential role helping cyber-insurance markets to mature and more dynamically calculate risk, should serve it well.”
   
• “The Enterprise Immune System is best described as an in-progress threat detection and response capability.”